Cosmos Health Statistics
Total Valuation
Cosmos Health has a market cap or net worth of $16.69 million. The enterprise value is $33.56 million.
| Market Cap | 16.69M |
| Enterprise Value | 33.56M |
Important Dates
The next estimated earnings date is Monday, August 17, 2026.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cosmos Health has 54.34 million shares outstanding. The number of shares has increased by 65.79% in one year.
| Current Share Class | 54.34M |
| Shares Outstanding | 54.34M |
| Shares Change (YoY) | +65.79% |
| Shares Change (QoQ) | +31.98% |
| Owned by Insiders (%) | 37.56% |
| Owned by Institutions (%) | 5.62% |
| Float | 33.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 4.39 |
| PS Ratio | 0.24 |
| Forward PS | 0.18 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.88.
| Current Ratio | 1.08 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.51 |
Financial Efficiency
Return on equity (ROE) is -92.33% and return on invested capital (ROIC) is -48.14%.
| Return on Equity (ROE) | -92.33% |
| Return on Assets (ROA) | -18.71% |
| Return on Invested Capital (ROIC) | -48.14% |
| Return on Capital Employed (ROCE) | -63.24% |
| Weighted Average Cost of Capital (WACC) | 20.76% |
| Revenue Per Employee | $426,302 |
| Profits Per Employee | -$129,646 |
| Employee Count | 163 |
| Asset Turnover | 1.16 |
| Inventory Turnover | 11.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.73% in the last 52 weeks. The beta is 4.15, so Cosmos Health's price volatility has been higher than the market average.
| Beta (5Y) | 4.15 |
| 52-Week Price Change | -35.73% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 65.71 |
| Average Volume (20 Days) | 22,954,835 |
Short Selling Information
The latest short interest is 4.74 million, so 8.73% of the outstanding shares have been sold short.
| Short Interest | 4.74M |
| Short Previous Month | 2.34M |
| Short % of Shares Out | 8.73% |
| Short % of Float | 13.98% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, Cosmos Health had revenue of $69.49 million and -$21.13 million in losses. Loss per share was -$0.59.
| Revenue | 69.49M |
| Gross Profit | 7.23M |
| Operating Income | -17.89M |
| Pretax Income | -21.13M |
| Net Income | -21.13M |
| EBITDA | -16.50M |
| EBIT | -17.89M |
| Loss Per Share | -$0.59 |
Balance Sheet
The company has $548,927 in cash and $17.42 million in debt, with a net cash position of -$16.87 million or -$0.31 per share.
| Cash & Cash Equivalents | 548,927 |
| Total Debt | 17.42M |
| Net Cash | -16.87M |
| Net Cash Per Share | -$0.31 |
| Equity (Book Value) | 19.83M |
| Book Value Per Share | 0.40 |
| Working Capital | 2.81M |
Cash Flow
In the last 12 months, operating cash flow was -$9.33 million and capital expenditures -$54,544, giving a free cash flow of -$9.38 million.
| Operating Cash Flow | -9.33M |
| Capital Expenditures | -54,544 |
| Depreciation & Amortization | 1.39M |
| Net Borrowing | 8.48M |
| Free Cash Flow | -9.38M |
| FCF Per Share | -$0.17 |
Margins
Gross margin is 10.40%, with operating and profit margins of -25.75% and -30.41%.
| Gross Margin | 10.40% |
| Operating Margin | -25.75% |
| Pretax Margin | -30.41% |
| Profit Margin | -30.41% |
| EBITDA Margin | -23.75% |
| EBIT Margin | -25.75% |
| FCF Margin | n/a |
Dividends & Yields
Cosmos Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -65.79% |
| Shareholder Yield | -65.79% |
| Earnings Yield | -126.63% |
| FCF Yield | -56.22% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Cosmos Health has an Altman Z-Score of -2.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.57 |
| Piotroski F-Score | 4 |